Demonstrates improved efficacy of photodynamic therapy in tumors, indicating a novel therapeutic approach.
Conjugating a tumor-biomarker-targeted nanobody with a photosensitizer significantly improved the efficacy of photodynamic therapy (PDT). This approach minimized nonspecific photosensitivity-related side effects by enhancing the aqueous solubility of the photosensitizer and enabling its specific accumulation in tumors.
No takes yet. Share an insight, caveat, or question.
Wan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: